Drug Interactions Update: Drugs, Herbs, and Oral Anticoagulation Article DOI:
Cite this article as: Wittkowsky, A.K. J Thromb Thrombolysis (2001) 12: 67. doi:10.1023/A:1012742628628 Abstract
Management of warfarin drug interactions is often complicated by lack of information regarding interactions with new drugs and with herbal medicinals. The pharmaceutical industry has increased both the number and quality of drug interaction studies prior to marketing new agents. Interactions may still occur in patients, however, despite negative pre-marketing studies in healthy volunteers. The clinical significance and intensity of warfarin interactions with prescription drugs (e.g., celecoxib, proton pump inhibitors, and selective serotonin reuptake inhibitors) can often be predicted on the basis of known metabolic characteristics of the drugs and warfarin enantiomers. Drug interactions with herbal medicinals are much more difficult to characterize and predict because of the lack of federal regulations regarding safety, efficacy, and manufacturing standards. Published case reports of interactions between warfarin and even the most widely used herbal medicinals are limited. Practitioners are encouraged to report such interactions through the FDA MedWatch program.
warfarin anticoagulation drug interactions herbal medicinals References
Marroum PJ, Uppoor RS, Parmelee T, et al. In vivo drug–drug interaction studies: a survey of all new molecular entities approved from 1987 to 1997.
Clin Pharmacol Ther
Karim A, Tolbert D, Piergies A, et al. Celecoxib does not significantly alter the pharmacokinetics or hypoprothrombinemic effects of warfarin in healthy subjects.
J Clin Pharmacol
Mersfelder TL, Stewart LR. Warfarin and celecoxibinteraction.
Haase KK, Rojas–Fernandez CH, Lane L, Frank DA. Potential interaction between celecoxib and warfarin.
Testa B, Jenner P. Inhibitors of cytochrome P450s and their mechanism of action.
Drug Metab Rev
Suftin T, Balmer K, Bostrom H, Eriksson S, Hoglund P, Paulson O. Stereoselective interaction of omeprazole with warfarin in healthy men.
Ther Drug Monitoring
Unge P, Svedberg LE, Nordgren A, Blom H, Andersson T, Lagerstrom PO. A study of the interaction of omeprazole and warfarin in anticoagulated patients.
Br J Clin Pharmacol
Andersson T. Pharmacokinetics, metabolism, and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.
Ahmad S. Omeprazole–warfarin interaction.
South J Med
Duncan D, Sayal K, McConnell H, Taylor D. Antidepressant interactions with warfarin.
Int Clin Psychopharm
Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow–up national survey.
Miller LG, Hume A, Harris IM, et al. White paper on herbal products.
Boullata JI, Nace AM. Safety issues with herbal medicine.
Liberti LE, Der Marderosian A. Evaluation of commercial ginseng products.
J Pharm Sci
Lui J, Garle M, Eneroth P, Bjorkhelm I. What do commercial ginseng preparations contain?
Janetzky K, Morreale AP. Probable interaction between warfarin and ginseng.
Am J Health Syst Pharm
Klepser TB, Klepser ME. Unsafe and potentially safe herbal therapies.
Am J Health–Syst Pharm
Heck AM, De Witt BA, Lukes AL. Potential interactions between alternative therapies and warfarin.
Am J Health–System Pharm
Spigset O. Reduced effect of warfarin caused by ubidecarenone.
Vaes LPJ, Chyka PA. Interactions of warfarin with garlic, ginger, ginko, or ginseng: nature of the evidence.
Yue QY, Bergquist C, Gerden B. Safety of St John's wort (Hypericum perforatum).
Roby CA, Anderson GD, Kantor E, Dryer DA, Burstein AH. St John's Wort: effect on CYP3A4 activity.
Clin Pharmacol Ther
Google Scholar Copyright information
© Kluwer Academic Publishers 2001